Your browser doesn't support javascript.
loading
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure.
Bosch, Agnes; Poglitsch, Marko; Kannenkeril, Dennis; Kolwelter, Julie; Striepe, Kristina; Ott, Christian; Rauh, Manfred; Schiffer, Mario; Achenbach, Stephan; Schmieder, Roland E.
Afiliação
  • Bosch A; Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Poglitsch M; Attoquant Diagnostics, Vienna, Austria.
  • Kannenkeril D; Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Kolwelter J; Department of Cardiology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Striepe K; Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Ott C; Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Rauh M; Department of Nephrology and Hypertension, Paracelsus Medical University, Nürnberg, Germany.
  • Schiffer M; Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Achenbach S; Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Schmieder RE; Department of Cardiology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
ESC Heart Fail ; 10(3): 1635-1642, 2023 06.
Article em En | MEDLINE | ID: mdl-36782339
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article